Veeva Systems Inc. Partners with Accumulus Technologies and DNAnexus to Enhance Regulatory Information Management
Reuters
Sep 02
<a href="https://laohu8.com/S/VEEV">Veeva Systems Inc.</a> Partners with Accumulus Technologies and DNAnexus to Enhance Regulatory Information Management
Veeva Systems Inc. has announced a strategic partnership with Accumulus Technologies and DNAnexus to enhance its Veeva RIM platform for regulatory information management. This collaboration aims to improve interoperability and facilitate seamless regulatory submissions by integrating Accumulus and Veeva RIM, allowing for instantaneous and simultaneous data sharing with over 70 regulatory agencies worldwide. Additionally, the integration with DNAnexus Trusted Regulatory Spaces promises to provide advanced data sharing capabilities for inter-agency collaboration, accelerating the approval process for regulated products. This partnership is expected to empower Veeva's mutual customers by expediting the delivery of treatments to patients.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF62469) on September 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.